NC
CNMD icon

NewSquare Capital’s CONMED CNMD Stock Holding History

NewSquare Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-104
Closed -$5.42K – 389
2025
Q2 		$5.42K Hold
104
– – ﹤0.01% 786
2025
Q1 		$6.28K Hold
104
– – ﹤0.01% 643
2024
Q4 		$7.12K Buy
+104
New +$7.25K ﹤0.01% 315

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NewSquare Capital's CNMD Position: Q3 2025 in Review

NewSquare Capital sold out of CONMED (CNMD) in Q3 2025, closing a stake of 104 shares — an estimated $5.42K sold.

NewSquare Capital first reported a position in CNMD in Q4 2024 and held it in 3 quarters. The position peaked at $7.12K in Q4 2024. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • NewSquare Capital reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 104 CONMED shares in Q3 2025, an estimated $5.42K.
  • NewSquare Capital first reported a position in CONMED in Q4 2024 and held it in 3 quarters.
  • NewSquare Capital's CONMED position peaked at $7.12K in Q4 2024.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.